After a rough 2022, smart investors know when to make the most of an opportunity. Look no further than beaten-down fintech companies, for example. At the moment, there’s a growing need for contactless payment solutions. Plus, there’s rising demand for “Buy Now Pay Later” services. Leading BNPL provider Affirm Holdings (NASDAQ:AFRM), for example, is in focus
0 Comments
Following a volatile year, investors may want to consider the best income stocks to buy in Jan. As the name suggests, these publicly traded securities offer regular passive income payouts with dividends (typically on a quarterly basis). Fundamentally, this financial category enables market participants to have their money work for them rather than the other
0 Comments
Could China-based electric vehicle (EV) manufacturer Kandi Technologies (NASDAQ:KNDI) be a hidden gem in your portfolio for the next three years? It’s worth considering, as KNDI stock is low now and has been much higher. Besides, Kandi is staking a claim in a niche EV market while also improving its bottom line. Kandi Technologies isn’t
0 Comments
The 21st century will be one dominated by connectivity and the internet. Already, 5G technology is ushering in a new era of smart cities, remote workforces, streaming video and powering virtual reality. And that, in my opinion, puts the attention squarely on cybersecurity stocks. Cybersecurity is critical for keeping our banking records private, our cloud
0 Comments
New Jersey-headquartered party supplies retailer Party City (NYSE:PRTY) has been in the headlines lately but not for reasons that investors would want to celebrate. It looks like PRTY stock is getting delisted and Party City is engaged in bankruptcy proceedings. Inflation and recession fears have taken a toll on the U.S. economy, and some businesses just
0 Comments
The world of pharmaceutical progress happens incrementally and exponentially. That is, therapies are iteratively improved while breakthrough treatments are also created and discovered. Investors who are curious to understand drug stocks with promising pipelines should start with these companies. 2023, like all years, holds the same promise of progress in the pharmaceutical sector: Iterative and
0 Comments
In this article CRM Follow your favorite stocksCREATE FREE ACCOUNT Signage on a Saleforce office building in San Francisco, California, U.S., on Tuesday, Feb. 23, 2021. David Paul Morris | Bloomberg | Getty Images Jeff Ubben’s Inclusive Capital has taken a position in Salesforce, according to sources, CNBC’s David Faber reported Monday. It’s unclear what
0 Comments
Although it may feel to many like the Russia-Ukraine War could last for a decade, the Rand Corporation, a prominent American think tank, recently outlined several scenarios that could cause the war to end relatively soon. Among these  events are Russian President Putin falling from power and the collapse of the Russian Army. Additionally, I
0 Comments